Top GLP-1 Weight-Loss Telehealth Providers of 2026
Quick answer
Ro Body scores highest in our 2026 comparison at 8.4/10. Ro prescribes only FDA-approved GLP-1s and passes through manufacturer direct-pay pricing, with the Wegovy pen from $199/month and the Zepbound KwikPen at $299-$449/month, on top of a membership that costs $39 the first month and then $149/month (as low as $74/month prepaid annually), with an insurance concierge for covered patients. WeightWatchers Clinic (8.3/10) is the strongest pick when insurance coordination matters most, and Sesame (8.2/10) is the value pick, with labs included from $59-$99/month. Across the category, expect roughly $250-$600/month all-in for cash-pay branded therapy. Efficacy belongs to the medications, not the platforms: in the randomized STEP 1 trial, semaglutide 2.4 mg produced a 14.9% mean body-weight reduction over 68 weeks versus 2.4% with placebo. Every option requires an eligibility screen and a licensed clinician's prescription; approval is never guaranteed.
GLP-1 telehealth pricing was rewritten in 2025-2026. The FDA declared the semaglutide shortage resolved in February 2025, the legal basis for mass-compounded copies wound down, and Novo Nordisk and Eli Lilly began selling Wegovy and Zepbound direct-to-consumer, pricing that most telehealth platforms now simply pass through. This directory compares six providers that verifiably operate in July 2026, from branded-only platforms (Ro, WeightWatchers Clinic, Sesame, Hims & Hers) to programs still centered on compounded medication (Mochi Health, Noom Med). Each entry separates the membership fee from the medication cost, spells out what the fee actually buys (labs, synchronous visits, insurance coordination), and lists provider-specific red flags. Scores weight Safety 30%, Evidence 30%, Cost & Value 20%, Transparency 10%, and Support 10%. All GLP-1 medications are prescription-only and require a provider evaluation; nothing here promises a treatment outcome.
How we scored: every product below was rated 0–10 on five weighted criteria — Safety (30%), Evidence (30%), Cost & Value (20%), Transparency (10%), and Support (10%). Commissions never affect scores or rank order. Read our full methodology.
2026 rankings at a glance
| # | Product | Rating | Best for | Price | Actions |
|---|---|---|---|---|---|
| 1 | Ro (Ro Body) | 8.4/10 | Cash-pay patients who want branded GLP-1s at manufacturer direct rates with insurance-coordination help | $39 first month, then $149/mo membership ($74/mo prepaid annually) + medication: Wegovy pill from $149/mo, Wegovy pen from $199/mo, Zepbound KwikPen $299-$449/mo cash-pay | |
| 2 | WeightWatchers Clinic (WW Med+)Not an affiliate — no commission earned | 8.3/10 | Insured patients who want hands-on prior-authorization help plus a structured behavioral program | $25 first month, then $74/mo Med+ membership on a 12-month plan; GLP-1 medication billed separately (insurance or cash-pay via manufacturer programs) | |
| 3 | Sesame (Success by Sesame) | 8.2/10 | Budget-conscious patients who want labs and live video visits included in a low program fee | $99/mo program ($59/mo with annual plan) incl. labs and video visits + medication: Wegovy pill $149-$299/mo, Wegovy pen $349/mo standard self-pay, Zepbound KwikPen $299-$698/mo | |
| 4 | Hims & Hers Weight LossNot an affiliate — no commission earned | 7.7/10 | Existing Hims/Hers users who want branded GLP-1s with app-first, async care | $39 first month, then $149/mo membership + medication: Wegovy pill from $149/mo, Wegovy pen from $199/mo, Zepbound vial/KwikPen from $299/mo cash-pay | |
| 5 | Mochi Health | 7.2/10 | Cash-pay patients prioritizing flat, dose-independent pricing who accept compounded-medication tradeoffs | $79/mo membership ($39 first month promo) + compounded semaglutide $99/mo or compounded tirzepatide $199/mo (all doses, shipping included); branded Wegovy/Zepbound also prescribable | |
| 6 | Noom MedNot an affiliate — no commission earned | 6.7/10 | App-driven users who want one all-inclusive bill and accept compounded-medication and billing caveats | GLP-1Rx: $129 to start, then $249/mo all-inclusive (compounded semaglutide); Microdose $199/mo; GLP-1Rx Plus $299/mo; branded-med telehealth tier $99/mo + medication cost |
Ro (Ro Body)
8.4/10Ro Body pairs a telehealth membership with FDA-approved GLP-1 medications sold at manufacturer direct-pay prices, plus an insurance concierge. Membership is $39 the first month and up to $149/month after, with medication billed separately. All medications require a provider evaluation and prescription.
- Prescribes only FDA-approved GLP-1s (Wegovy, Zepbound, Ozempic, orforglipron) since the compounding wind-down
- Red flag: Lilly's 45-day refill check-in window applies to discounted high-dose Zepbound; miss it and refills reprice at $499-$699/month full cash price
(affiliate link)
WeightWatchers Clinic (WW Med+)
8.3/10WeightWatchers Clinic combines telehealth prescribing of FDA-approved GLP-1s with WW's behavioral program and a dedicated insurance coordinator. Med+ membership is $25 for the first month on a 12-month plan, then $74/month, with medication billed separately. Prescriptions depend on clinician eligibility screening.
- Prescribes only FDA-approved medications (Wegovy, Zepbound, Saxenda, Wegovy pill); never sold mass-compounded GLP-1s as its core offer
- Red flag: the 12-month Med+ plan auto-renews for another 12-month period at the same monthly rate, and the parent company only emerged from Chapter 11 bankruptcy in mid-2025
Sesame (Success by Sesame)
8.2/10Success by Sesame bundles video visits, messaging, and lab work into a program starting at $59-$99/month, with FDA-approved GLP-1s billed separately at manufacturer-aligned cash prices or through insurance. As a marketplace, individual clinicians set their own prices. All medications require a prescription after clinician evaluation.
- Labs are included in the program fee, which is rare among GLP-1 telehealth programs
- Red flag: Sesame is a marketplace where clinicians set their own prices, so the advertised $59-$99/month rate is a floor, not a guarantee, and care continuity depends on the individual provider you book
(affiliate link)
Hims & Hers Weight Loss
7.7/10Hims & Hers offers branded GLP-1s (Wegovy, Ozempic, Zepbound, Foundayo) from $149/month medication cost plus a $39-then-$149/month membership, after exiting compounded semaglutide in a March 2026 settlement with Novo Nordisk. Intake is async-first, and a provider evaluation and prescription are required.
- Branded FDA-approved lineup post-settlement: Wegovy pill and pen, Ozempic, Zepbound vial and KwikPen, Foundayo
- Red flag: Hims marketed compounded semaglutide at scale until Novo Nordisk's February 2026 patent lawsuit; it exited compounding via the March 9, 2026 settlement, and grandfathered compounded patients are being transitioned off through mid-2026
Mochi Health
7.2/10Mochi Health charges a flat $79/month membership plus $99/month for compounded semaglutide or $199/month for compounded tirzepatide at any dose, with obesity-medicine physicians and unlimited visits. Branded options are available too. Compounded GLP-1s are not FDA-approved, and all medications require provider evaluation and a prescription.
- Flat medication pricing at every dose: $99/mo compounded semaglutide, $199/mo compounded tirzepatide, shipping included
- Red flag: the core offering is compounded semaglutide and tirzepatide, which are not FDA-reviewed for safety, effectiveness, or quality, and whose legal availability is uncertain now that the FDA shortages resolved in 2025 ended the main basis for mass compounding
(affiliate link)
Noom Med
6.7/10Noom Med wraps clinician care, medication, and Noom's coaching app into all-inclusive plans from $199-$299/month, most built on compounded GLP-1s, plus a $99/month tier for branded prescriptions. Compounded drugs are not FDA-approved, and every plan requires eligibility screening and a clinician's prescription.
- All-inclusive pricing: clinical care, medication, and the Noom app in one quarterly-billed fee
- Red flag: core GLP-1Rx tiers are built on compounded semaglutide and tirzepatide even after the FDA declared the shortages resolved in 2025, and Noom's own disclosure notes compounded drugs are not FDA-reviewed for safety, efficacy, or quality
Frequently asked questions
Do you earn money from these recommendations?
Yes, partially. Ro, Sesame, and Mochi Health links on this page are affiliate links, and we may earn a commission if you sign up through them. Hims & Hers, Noom Med, and WeightWatchers Clinic earn us nothing. Rankings are set by our published methodology (Safety 30%, Evidence 30%, Cost & Value 20%, Transparency 10%, Support 10%) before monetization is considered, which is why non-partner providers appear throughout the list.
Is compounded semaglutide still legal and safe in 2026?
Mass compounding was allowed only while FDA listed semaglutide and tirzepatide in shortage; those shortages were declared resolved in 2025, so pharmacies may now compound copies only for patients whose medical needs cannot be met by the approved product. Compounded GLP-1s are not FDA-reviewed for safety, effectiveness, or quality, and published case reports document 10-fold dosing errors from compounded vials. Providers still centered on compounded medication carry regulatory and supply risk.
Will insurance cover GLP-1 weight-loss medication through telehealth?
Sometimes. Coverage for Wegovy and Zepbound varies widely by plan and often requires prior authorization. WeightWatchers Clinic and Ro assign insurance coordinators to pursue coverage; Sesame accepts insurance for medications (copays can be as low as $25/month). Membership or program fees themselves are almost always self-pay.
What does GLP-1 telehealth actually cost per month in 2026?
Two bills: a program fee ($0-$149/month, e.g., $74/month at WeightWatchers Clinic or $59-$99/month at Sesame with labs included) plus medication (cash-pay branded GLP-1s run $149-$499/month at manufacturer direct rates; compounded programs run $99-$299/month all-in). Typical all-in cash-pay totals are roughly $250-$600/month.
Can I get a GLP-1 prescription without seeing a doctor?
No. Every legitimate platform requires evaluation by a licensed clinician, and BMI-based eligibility criteria apply (generally BMI >= 30, or >= 27 with a weight-related condition). Some platforms use asynchronous questionnaires rather than video visits, which is faster but means less clinical screening, and platforms with no lab work or live visit deserve extra scrutiny.
Get evidence-based health picks in your inbox — no hype.
Join The Firsthand Brief for a weekly, research-first read.
We never sell your email. Unsubscribe anytime. See our privacy policy.